Basic Information | Post buying leads | Suppliers |
Name |
Cadmium-thioneine |
EINECS | N/A |
CAS No. | 73419-42-8 | Density | g/cm3 |
PSA | N/A | LogP | N/A |
Solubility | N/A | Melting Point |
N/A |
Formula | C18H30N6O4S2•Cd | Boiling Point | °Cat760mmHg |
Molecular Weight | 571.06 | Flash Point | °C |
Transport Information | N/A | Appearance | N/A |
Safety | Confirmed human carcinogen. Deadly poison by intravenous route. When heated to decomposition it emits very toxic fumes of NOx, SOx, and Cd. See also CADMIUM COMPOUNDS. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
N/A |
IUPAC Name: Cadmium(2+); 3-(2-sulfido-1H-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate
Synonyms of Cadmium-thioneine (CAS NO.73419-42-8): Cadmium-binding protein ; Cadmium-metallothionen
CAS NO: 73419-42-8
Molecular Formula of Cadmium-thioneine (CAS NO.73419-42-8): C18H28CdN6O4S2
Molecular Weight: 568.9937
H bond acceptors: 5
H bond donors of Cadmium-thioneine (CAS NO.73419-42-8): 2
Freely Rotating Bonds: 4
Polar Surface Area: 93.92 Å2
Molecular Structure:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
rabbit | LD50 | intravenous | 320ug/kg (0.32mg/kg) | Biochemical Pharmacology. Vol. 26, Pg. 25, 1977. | |
rat | LD50 | intravenous | 280ug/kg (0.28mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Biochemical Pharmacology. Vol. 26, Pg. 25, 1977. |
Cadmium and its compounds are on the Community Right-To-Know List.
Confirmed human carcinogen. Deadly poison by intravenous route. When heated to decomposition it emits very toxic fumes of NOx, SOx, and Cd. See also CADMIUM COMPOUNDS.
OSHA PEL: TWA 5 µg(Cd)/m3
ACGIH TLV: TWA 0.002 mg(Cd)/m3 (respirable dust), Suspected Human Carcinogen); BEI: 5 µg/g creatinine in urine; 5 µg/L in blood
NIOSH REL: (Cadmium) Reduce to lowest feasible level